The federal parliament endorsed the enabling legislation last year with no debate or real scrutiny despite public recognition of 'unintended consequences' in the form of undesirable delistings of PBS-listed medicines. …
Few should expect 'ministerial discretion' and few should actually apply
July 4, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
First patient enrolled in new trial of NovoSorb SynPath treatment
August 11, 2022 - - Australian Biotech -
Partrys' candidate in combination improves survival in brain cancer model
August 11, 2022 - - Australian Biotech -
Scrapped COVIDSafe app only identified two positive cases
August 11, 2022 - - Other Health -
Compare the Market investor moves to acquire all of iSelect
August 11, 2022 - - Other Health -
New report promotes expansion of short-stay hospital program
August 11, 2022 - - Other Health -
Critical decisions over two months and four sitting weeks
August 11, 2022 - - Latest News -
UK push to lead the world on genetic profiling of cancer patients
August 11, 2022 - - Latest News